MetaCap

MaxCyte Quarterly Cash Flow Statement

NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

1.37+0.09 (+7.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MaxCyte free cash flow

In the quarter ended Sep 30, 2026, MaxCyte generated -$5.5 million of operating cash flow and spent $59,000 on capital expenditures. That left free cash flow of -$5.6 million, a free-cash-flow margin of -54.8% of revenue. MaxCyte returned $4.0 million to shareholders through share repurchases.

Summary generated from market data by MetaCap's automated system. Methodology

MaxCyte cash flow statement (quarterly)

MaxCyte quarterly cash flow statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Net Income-4.76M-8.87M-4.75M-9.60M-12.42M-12.36M-10.26M-10.60M-11.56M-9.38M-9.53M-5.28M
Net Income growth (YoY)————————————
Depreciation & Amortization900.00K978.00K1.05M1.07M1.07M1.10M1.10M1.06M1.07M1.08M1.11M1.10M
Stock-Based Compensation963.00K1.16M1.14M706.00K1.95M3.51M3.04M3.13M3.37M3.56M3.02M3.57M
Change in Working Capital-2.11M-13.00K-5.02M1.48M2.02M-585.00K-7.16M-945.00K3.81M1.68M-3.37M2.67M
Operating Cash Flow-5.51M-4.66M-8.17M-2.69M-7.46M-9.85M-14.41M-7.82M-4.39M-4.83M-10.56M981.00K
Capital Expenditures-59.00K-62.00K-72.00K-231.00K-300.00K-584.00K-653.00K-147.00K-406.00K-294.00K-804.00K-915.00K
Investing Cash Flow7.86M6.57M2.66M9.68M5.19M1.54M9.53M-1.67M3.61M19.39M-14.40M-4.14M
Share Repurchases-4.02M———————————
Financing Cash Flow-4.02M-1.42M5.00K105.00K14.00K154.00K383.00K412.00K228.00K713.00K703.00K493.00K
Net Change in Cash-1.67M485.00K-5.51M7.09M-2.25M-8.16M-4.50M-9.07M-555.00K15.26M-24.26M-2.67M
Free Cash Flow-5.57M-4.72M-8.24M-2.92M-7.76M-10.44M-15.06M-7.97M-4.80M-5.13M-11.37M66.00K

This table shows 12 quarterly periods of MaxCyte's cash flow statement, from Q3 2026 back to Q4 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MXCT's reporting calendar. What is a cash flow statement?

More financial data